久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Q and A with CEO

Serving in the name of progress

By Zhong Nan | China Daily | Updated: 2017-09-08 07:29

Serving in the name of progress

Joaquin Duato, executive vice-president and worldwide chairman of pharmaceuticals at Johnson & Johnson. [Photo provided to China Daily]

A senior executive at Johnson & Johnson talks about the group's strategy in China and the rest of the world

Joaquin Duato had dreams of playing tennis for Spain as a child.

At 55, he is now the executive vice-president and worldwide chairman of pharmaceuticals at blue chip brand Johnson& Johnson.

"I'm an avid tennis player and as a child I used to dream of one day representing Spain," he said during a visit to Beijing.

Instead he has represented the global healthcare giant for the past 28 years and helped shape the multinational's strategy in China and across the world.

"The healthcare and pharmaceutical industries have developed notably in China during the past three decades," Duato said. "Pharmaceutical companies are getting medicines to patients faster than they were before."

Moves by the China Food and Drug Administration to streamline the approval of new medicines have opened up the industry along with updating the National Reimbursement Drug List.

Last month, the Johnson & Johnson subsidiary, Xi'an Janssen Pharmaceutical Ltd, was granted approval from the CFDA for its Imbruvica capsules, which are used to treat adult patients with chronic lymphocytic leukemia and mantle cell lymphoma.

"These factors have improved the situation in China for innovation-based pharmaceutical companies," Duato added.

With more than 125,000 staff in nearly 60 countries and regions, Johnson & Johnson sells its products, such as consumer and healthcare, pharmaceuticals and medical devices, in about 200 nations and regions.

Naturally, China has become "vitally" important to the United States-based group.

In an interview with China Daily, Duato talked about the company's vision, its strategy in China, and his love of tennis and giant pandas.

What are Johnson & Johnson's plans in China during the next five years?

China is vitally important to us globally and we remain committed to investing in China, and making a significant contribution to the country's economic growth.

Since establishing operations here in 1985, we have expanded our presence significantly and today employ more than 2,500 people in our Beijing headquarters, our state-of-the-art manufacturing site in Xi'an, and our research and development operations. These include the groundbreaking R&D center in Shanghai and the Johnson & Johnson Innovation Center.

Following an investment of $290 million, our new supply chain hub for innovation in Asia is scheduled to open in Xi'an (in Shaanxi province) in 2019. The objective is to serve the rapidly expanding needs of China and other markets in the region. The plant is expected to set a new standard in pharmaceutical manufacturing here.

At full capacity, the plant is expected to produce 400 million tablets, capsules, creams, suppositories and powders a year.

What are your priorities in the country?

Globally, and in China, our strategy is to focus on discovering and developing transformational medical innovations for patients in six high priority disease areas, which address major unmet (unfulfilled) treatment needs.

These include oncology, immunology, neuroscience, infectious diseases, cardiovascular and pulmonary hypertension.

We will (also) continue to support China's aspiration to become a leading global pharmaceutical innovator through forward-looking investments. This will enable the discovery of game-changing therapies which address unmet medical needs.

What business opportunities will emerge through the Belt and Road Initiative?

Xi'an Janssen was, and will continue to be, a forerunner in establishing joint ventures with local partners in China. We established our operations in Shaanxi province in 1985, a critical area of the Belt and Road Initiative.

We also attribute these joint-venture partnerships and our continued investment in Xi'an as critical factors to our success in China. We will continue this model (in the future).

What is your biggest achievement here?

I am proud of guiding the business toward a greater focus on transformational medical innovations for patients.

Zytiga, a new kind of treatment for men with (a type of) prostate cancer, is a great example of cutting-edge science and true medical innovation that significantly prolongs lives.

How will you compete with competitors across the world and in China?

In 2011, we made the decision to focus our business on identifying and bringing transformational medical innovation. We are an innovation-based company which globally spends 50 percent more in research and development than in sales and marketing.

With a growing core business of medicines and a strong lineup of innovative products expected to launch or file during the next five years, we are leading the industry in advancing the health of patients around the world.

With our proven global commercial capabilities, we are well-positioned to continue delivering strong, long-term, sustainable growth.

How does digital technology affect your business?

Digital technology is important in discovery and development because we use information technology to screen targets and to model our clinical trial designs.

It is critical in manufacturing as we use machine learning and artificial intelligence, or AI, to identify areas in which we can eliminate waste and establish better quality control measures.

We now have access to vast amounts of data about how our medicines are used by physicians and patients once they are on the market. So this helps us better understand the risk-benefit ratio.

What makes an effective leader of a major multinational company?

I am proud to have worked at Johnson & Johnson for more than 28 years. I have had a varied career in different sectors of the healthcare industry, and in different countries and regions around the world. This has helped me continue to evolve and adapt my leadership style.

For the first half of my career, I was based in Europe and I was successful by using a direct, straight forward leadership style. But after moving to the United States I had to re-evaluate my style and learn to navigate cultural differences.

I would say my key leadership approach is adaptability-being able to draw upon what best suits the situation and the team I am leading.

How has your style changed over time?

Different business challenges need different leadership styles. When I became the head of our North American operation, I had to work quickly and alone to guide the business through a challenging turnaround.

But once it had stabilized, I had to open up to a more inclusive and consultative leadership style as we developed a long-term strategy for growth.

How do you handle setbacks?

I view setbacks as opportunities to grow, both as an individual and as a business. The challenges and hardships our group faced during the 2007 recession can almost be seen as a necessary step in achieving the remarkable success we have today.

The setbacks we faced forced us to make our organization a leaner and more focused operation. Our extremely successful model of embracing innovation was born.

So now, whenever I am faced with a setback, I always look for an opportunity that might arise.

What are your hobbies?

My role involves a lot of travel, so whenever I am at home my first priority is spending time with my family. I love being with my wife, son and daughter.

This summer, I have spent a number of days traveling with my family to visit potential colleges that my daughter might attend next year.

I am also an avid tennis player and as a child I used to dream of one day representing Spain.

How do you spend your free time in China?

Usually, I am focused on meetings with customers and government officials. But I understand that through our collaboration with Shaanxi Rare Wild Animals Rescue and Research Center, which aims to further protect the giant panda in China, we had the honor of naming a baby panda "Johnson& Johnson". If I have free time, I am hoping to visit him.

CV

Age: 55

Nationality: Spanish and American

Career:

2017 onwards: Chairman of the Board, PhRMA

2011 onwards: Worldwide Chairman, Pharmaceuticals, Johnson& Johnson

2009-11: Company Group Chairman, Americas, The Janssen Pharmaceutical Companies of Johnson& Johnson

2007-09: Company Group Chairman, Diagnostics, Johnson & Johnson

2005-07: President, Ortho Biotech Products LP, Johnson& Johnson

Education: Undergraduate degree in Economics and Business

MBA from ESADE, Barcelona

Masters of International Management from Thunderbird, Phoenix, US.

Family: Married with a son and a daughter

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    亚洲午夜久久久久| 日本一区中文字幕| 日本韩国欧美三级| 亚洲欧美成aⅴ人在线观看| 欧洲av在线精品| 天堂资源在线中文精品| 91精品国产福利在线观看| 黄色日韩网站视频| 亚洲国产精品黑人久久久| 色噜噜偷拍精品综合在线| 午夜激情一区二区| 精品美女在线播放| 北条麻妃一区二区三区| 亚洲综合图片区| 日韩欧美另类在线| 岛国一区二区在线观看| 亚洲一区二区精品视频| 欧美电影免费观看高清完整版在线观看| 国产做a爰片久久毛片| 中文字幕制服丝袜一区二区三区 | 久久久久久亚洲综合| 成人黄色777网| 婷婷激情综合网| 久久久久久综合| 在线观看免费一区| 精品亚洲国产成人av制服丝袜| 中文字幕一区二区三区视频 | 91精品国产综合久久福利软件| 国产精品一区二区三区四区| 亚洲靠逼com| 精品国产一区久久| 91免费视频网| 麻豆国产一区二区| 国产精品丝袜久久久久久app| 欧美日韩综合不卡| 国产精品123| 日日摸夜夜添夜夜添国产精品| 国产农村妇女毛片精品久久麻豆| 欧美日韩亚州综合| 国产精品一区一区| 午夜国产不卡在线观看视频| 国产日韩欧美激情| 在线播放国产精品二区一二区四区 | 亚洲精品久久久久久国产精华液| 欧美大尺度电影在线| 一本一本大道香蕉久在线精品| 老司机精品视频在线| 亚洲黄色小视频| 久久精品亚洲精品国产欧美| 欧美日韩中文一区| 成人动漫一区二区三区| 久久成人精品无人区| 亚洲午夜电影网| 国产精品久久久久桃色tv| 日韩欧美123| 欧美午夜一区二区三区免费大片| 国产不卡视频在线播放| 热久久国产精品| 一个色综合网站| 亚洲国产精品高清| 精品噜噜噜噜久久久久久久久试看| 在线亚洲人成电影网站色www| 国产成人自拍网| 久久国产精品一区二区| 亚洲va欧美va天堂v国产综合| 国产精品久久久久四虎| 亚洲精品在线网站| 4438x成人网最大色成网站| 一本色道a无线码一区v| 成人自拍视频在线| 韩国av一区二区三区| 日韩精品每日更新| 亚洲第一二三四区| 亚洲人成精品久久久久| 国产精品无码永久免费888| 精品久久国产老人久久综合| 777奇米四色成人影色区| 日本高清无吗v一区| 波多野结衣精品在线| 国产精品911| 国产在线国偷精品免费看| 日本视频在线一区| 一区二区三区四区高清精品免费观看| 国产片一区二区三区| 久久久久国产精品麻豆ai换脸 | 欧美一区二区三区在线观看| 日本精品视频一区二区三区| heyzo一本久久综合| 福利一区二区在线| 国产精品一区二区在线观看不卡| 极品少妇xxxx偷拍精品少妇| 日本成人中文字幕| 日韩精品成人一区二区在线| 午夜精品123| 三级欧美韩日大片在线看| 亚洲成a人在线观看| 亚洲电影一级片| 亚洲国产精品久久久久秋霞影院| 亚洲综合丁香婷婷六月香| 一区二区三区电影在线播| 亚洲欧美日韩国产另类专区| 亚洲欧美日韩国产综合| 一区二区在线观看免费视频播放| 亚洲视频中文字幕| 亚洲人吸女人奶水| 一区二区三区成人| 亚洲国产欧美在线人成| 午夜久久电影网| 亚洲制服丝袜av| 亚洲成人综合在线| 亚洲va天堂va国产va久| 日本亚洲一区二区| 精东粉嫩av免费一区二区三区 | 久久99国产精品免费| 极品瑜伽女神91| 国产成人综合网站| www.成人网.com| 91黄色免费版| 精品视频一区 二区 三区| 欧美久久婷婷综合色| 日韩一区二区免费视频| 精品国产伦一区二区三区免费| 欧美精品一区二区久久久| 久久精品视频免费| 国产精品伦一区二区三级视频| 最近日韩中文字幕| 亚洲一区二区三区四区不卡| 日韩精品乱码av一区二区| 久久99国产精品久久99果冻传媒 | 国产一区二区免费在线| 大白屁股一区二区视频| 91丨九色丨黑人外教| 欧美日韩综合不卡| 欧美不卡123| 中文欧美字幕免费| 一区二区三区波多野结衣在线观看| 午夜国产精品一区| 国产一二精品视频| 91麻豆国产福利在线观看| 欧美精品在线观看一区二区| 久久综合一区二区| 亚洲欧洲性图库| 日韩二区在线观看| 粉嫩一区二区三区在线看| 91国产成人在线| 欧美成人伊人久久综合网| 亚洲国产精品成人综合| 亚洲欧美aⅴ...| 麻豆91免费观看| 懂色av中文一区二区三区| 91久久精品一区二区三区| 欧美精品第1页| 久久久不卡影院| 一区二区三区在线视频免费观看| 图片区小说区国产精品视频| 国产伦精品一区二区三区免费迷 | 欧美精品一区二区三区四区| 亚洲日本中文字幕区| 日韩国产欧美在线视频| 成人小视频在线| 777奇米成人网| 国产精品乱人伦| 日韩国产欧美在线播放| 成人动漫一区二区| 日韩视频免费直播| 亚洲三级在线播放| 精东粉嫩av免费一区二区三区 | 91免费国产在线观看| 日韩午夜电影在线观看| 亚洲视频资源在线| 韩日av一区二区| 欧美色视频一区| 国产精品污www在线观看| 日精品一区二区三区| 99国产欧美另类久久久精品| 日韩精品中文字幕一区| 亚洲精品视频一区二区| 国产一区二三区| 欧美日韩精品一区二区三区蜜桃| 国产欧美日韩另类视频免费观看| 视频一区二区国产| 99re热这里只有精品免费视频| 欧美电视剧免费全集观看| 夜夜操天天操亚洲| 成人在线视频首页| 日韩精品中文字幕一区二区三区| 亚洲激情在线激情| 国产jizzjizz一区二区| 欧美一区二区三区日韩视频| 亚洲欧美另类久久久精品 | 成人丝袜高跟foot| 欧美电影精品一区二区| 亚洲一区二区三区四区中文字幕| 成人自拍视频在线观看| 亚洲精品一区二区三区蜜桃下载| 亚洲成人福利片| 91久久精品网| 国产精品激情偷乱一区二区∴| 国产一区二三区| 日韩欧美一级二级|